781 MORE AGGRESSIVE LDL-C AND NON-HDL-C TARGETS MUST BE ACHIEVED IN PATIENTS RECEIVING LIPID-LOWERING THERAPY TO NORMALIZE APOB-CONTAINING LIPOPROTEINS
Publication
, Conference
Betteridqe, J; Guyton, JR; Farmer, M; Leiter, LA; Lin, J; Shah, A; Johnson-Levonas, AO; Brudi, P
Published in: Atherosclerosis Supplements
June 2011
Duke Scholars
Published In
Atherosclerosis Supplements
DOI
ISSN
1567-5688
Publication Date
June 2011
Volume
12
Issue
1
Start / End Page
163 / 164
Publisher
Elsevier BV
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Betteridqe, J., Guyton, J. R., Farmer, M., Leiter, L. A., Lin, J., Shah, A., … Brudi, P. (2011). 781 MORE AGGRESSIVE LDL-C AND NON-HDL-C TARGETS MUST BE ACHIEVED IN PATIENTS RECEIVING LIPID-LOWERING THERAPY TO NORMALIZE APOB-CONTAINING LIPOPROTEINS. In Atherosclerosis Supplements (Vol. 12, pp. 163–164). Elsevier BV. https://doi.org/10.1016/s1567-5688(11)70782-6
Betteridqe, J., J. R. Guyton, M. Farmer, L. A. Leiter, J. Lin, A. Shah, A. O. Johnson-Levonas, and P. Brudi. “781 MORE AGGRESSIVE LDL-C AND NON-HDL-C TARGETS MUST BE ACHIEVED IN PATIENTS RECEIVING LIPID-LOWERING THERAPY TO NORMALIZE APOB-CONTAINING LIPOPROTEINS.” In Atherosclerosis Supplements, 12:163–64. Elsevier BV, 2011. https://doi.org/10.1016/s1567-5688(11)70782-6.
Betteridqe J, Guyton JR, Farmer M, Leiter LA, Lin J, Shah A, et al. 781 MORE AGGRESSIVE LDL-C AND NON-HDL-C TARGETS MUST BE ACHIEVED IN PATIENTS RECEIVING LIPID-LOWERING THERAPY TO NORMALIZE APOB-CONTAINING LIPOPROTEINS. In: Atherosclerosis Supplements. Elsevier BV; 2011. p. 163–4.
Betteridqe, J., et al. “781 MORE AGGRESSIVE LDL-C AND NON-HDL-C TARGETS MUST BE ACHIEVED IN PATIENTS RECEIVING LIPID-LOWERING THERAPY TO NORMALIZE APOB-CONTAINING LIPOPROTEINS.” Atherosclerosis Supplements, vol. 12, no. 1, Elsevier BV, 2011, pp. 163–64. Crossref, doi:10.1016/s1567-5688(11)70782-6.
Betteridqe J, Guyton JR, Farmer M, Leiter LA, Lin J, Shah A, Johnson-Levonas AO, Brudi P. 781 MORE AGGRESSIVE LDL-C AND NON-HDL-C TARGETS MUST BE ACHIEVED IN PATIENTS RECEIVING LIPID-LOWERING THERAPY TO NORMALIZE APOB-CONTAINING LIPOPROTEINS. Atherosclerosis Supplements. Elsevier BV; 2011. p. 163–164.
Published In
Atherosclerosis Supplements
DOI
ISSN
1567-5688
Publication Date
June 2011
Volume
12
Issue
1
Start / End Page
163 / 164
Publisher
Elsevier BV
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology